Global Biotechnology 麻豆原创 Research Report 2024

Publication ID:

PB501246571

Publication Date:

January 10, 2024

Pages:

101

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies.
The global Biotechnology market was valued at US$ 514060 million in 2023 and is anticipated to reach US$ 857040 million by 2030, witnessing a CAGR of 7.4% during the forecast period 2024-2030.
North American market for Biotechnology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Biotechnology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Biotechnology in Health is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Biotechnology include Johnson & Johnson, Roche, Pfizer, Merck, Sanofi, AstraZeneca, Gilead, CELGENE CORPORATION and Biogen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biotechnology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biotechnology.
Report Scope
The Biotechnology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biotechnology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biotechnology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Johnson & Johnson
Roche
Pfizer
Merck
Sanofi
AstraZeneca
Gilead
CELGENE CORPORATION
Biogen
Amgen
Abbott
Novo Nordisk
Novartis
Lonza
BioNTech
Moderna
Regeneron
Vertex
Jazz Pharmaceuticals
Incyte
BioMarin
Genmab
Novavax
Segment by Type
DNA Sequencing
Nanobiotechnology
Tissue Engineering and Regeneration
Fermentation
Cell Based Assay
PCR Technology
Chromatography 麻豆原创
Others
Segment by Application
Health
Food & Agriculture
Natural Resources & Environment
Industrial Processing
Bioinformatics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biotechnology companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Biotechnology 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 DNA Sequencing
1.2.3 Nanobiotechnology
1.2.4 Tissue Engineering and Regeneration
1.2.5 Fermentation
1.2.6 Cell Based Assay
1.2.7 PCR Technology
1.2.8 Chromatography 麻豆原创
1.2.9 Others
1.3 麻豆原创 by Application
1.3.1 Global Biotechnology 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Health
1.3.3 Food & Agriculture
1.3.4 Natural Resources & Environment
1.3.5 Industrial Processing
1.3.6 Bioinformatics
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biotechnology 麻豆原创 Perspective (2019-2030)
2.2 Biotechnology Growth Trends by Region
2.2.1 Global Biotechnology 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biotechnology Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Biotechnology Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Biotechnology 麻豆原创 Dynamics
2.3.1 Biotechnology Industry Trends
2.3.2 Biotechnology 麻豆原创 Drivers
2.3.3 Biotechnology 麻豆原创 Challenges
2.3.4 Biotechnology 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biotechnology Players by Revenue
3.1.1 Global Top Biotechnology Players by Revenue (2019-2024)
3.1.2 Global Biotechnology Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Biotechnology 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biotechnology Revenue
3.4 Global Biotechnology 麻豆原创 Concentration Ratio
3.4.1 Global Biotechnology 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biotechnology Revenue in 2023
3.5 Biotechnology Key Players Head office and Area Served
3.6 Key Players Biotechnology Product Solution and Service
3.7 Date of Enter into Biotechnology 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Biotechnology Breakdown Data by Type
4.1 Global Biotechnology Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Biotechnology Forecasted 麻豆原创 Size by Type (2025-2030)
5 Biotechnology Breakdown Data by Application
5.1 Global Biotechnology Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Biotechnology Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Biotechnology 麻豆原创 Size (2019-2030)
6.2 North America Biotechnology 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biotechnology 麻豆原创 Size by Country (2019-2024)
6.4 North America Biotechnology 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biotechnology 麻豆原创 Size (2019-2030)
7.2 Europe Biotechnology 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biotechnology 麻豆原创 Size by Country (2019-2024)
7.4 Europe Biotechnology 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biotechnology 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Biotechnology 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biotechnology 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Biotechnology 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biotechnology 麻豆原创 Size (2019-2030)
9.2 Latin America Biotechnology 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biotechnology 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Biotechnology 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biotechnology 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Biotechnology 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biotechnology 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Biotechnology 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Biotechnology Introduction
11.1.4 Johnson & Johnson Revenue in Biotechnology Business (2019-2024)
11.1.5 Johnson & Johnson Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Biotechnology Introduction
11.2.4 Roche Revenue in Biotechnology Business (2019-2024)
11.2.5 Roche Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Biotechnology Introduction
11.3.4 Pfizer Revenue in Biotechnology Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Biotechnology Introduction
11.4.4 Merck Revenue in Biotechnology Business (2019-2024)
11.4.5 Merck Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Biotechnology Introduction
11.5.4 Sanofi Revenue in Biotechnology Business (2019-2024)
11.5.5 Sanofi Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Biotechnology Introduction
11.6.4 AstraZeneca Revenue in Biotechnology Business (2019-2024)
11.6.5 AstraZeneca Recent Development
11.7 Gilead
11.7.1 Gilead Company Detail
11.7.2 Gilead Business Overview
11.7.3 Gilead Biotechnology Introduction
11.7.4 Gilead Revenue in Biotechnology Business (2019-2024)
11.7.5 Gilead Recent Development
11.8 CELGENE CORPORATION
11.8.1 CELGENE CORPORATION Company Detail
11.8.2 CELGENE CORPORATION Business Overview
11.8.3 CELGENE CORPORATION Biotechnology Introduction
11.8.4 CELGENE CORPORATION Revenue in Biotechnology Business (2019-2024)
11.8.5 CELGENE CORPORATION Recent Development
11.9 Biogen
11.9.1 Biogen Company Detail
11.9.2 Biogen Business Overview
11.9.3 Biogen Biotechnology Introduction
11.9.4 Biogen Revenue in Biotechnology Business (2019-2024)
11.9.5 Biogen Recent Development
11.10 Amgen
11.10.1 Amgen Company Detail
11.10.2 Amgen Business Overview
11.10.3 Amgen Biotechnology Introduction
11.10.4 Amgen Revenue in Biotechnology Business (2019-2024)
11.10.5 Amgen Recent Development
11.11 Abbott
11.11.1 Abbott Company Detail
11.11.2 Abbott Business Overview
11.11.3 Abbott Biotechnology Introduction
11.11.4 Abbott Revenue in Biotechnology Business (2019-2024)
11.11.5 Abbott Recent Development
11.12 Novo Nordisk
11.12.1 Novo Nordisk Company Detail
11.12.2 Novo Nordisk Business Overview
11.12.3 Novo Nordisk Biotechnology Introduction
11.12.4 Novo Nordisk Revenue in Biotechnology Business (2019-2024)
11.12.5 Novo Nordisk Recent Development
11.13 Novartis
11.13.1 Novartis Company Detail
11.13.2 Novartis Business Overview
11.13.3 Novartis Biotechnology Introduction
11.13.4 Novartis Revenue in Biotechnology Business (2019-2024)
11.13.5 Novartis Recent Development
11.14 Lonza
11.14.1 Lonza Company Detail
11.14.2 Lonza Business Overview
11.14.3 Lonza Biotechnology Introduction
11.14.4 Lonza Revenue in Biotechnology Business (2019-2024)
11.14.5 Lonza Recent Development
11.15 BioNTech
11.15.1 BioNTech Company Detail
11.15.2 BioNTech Business Overview
11.15.3 BioNTech Biotechnology Introduction
11.15.4 BioNTech Revenue in Biotechnology Business (2019-2024)
11.15.5 BioNTech Recent Development
11.16 Moderna
11.16.1 Moderna Company Detail
11.16.2 Moderna Business Overview
11.16.3 Moderna Biotechnology Introduction
11.16.4 Moderna Revenue in Biotechnology Business (2019-2024)
11.16.5 Moderna Recent Development
11.17 Regeneron
11.17.1 Regeneron Company Detail
11.17.2 Regeneron Business Overview
11.17.3 Regeneron Biotechnology Introduction
11.17.4 Regeneron Revenue in Biotechnology Business (2019-2024)
11.17.5 Regeneron Recent Development
11.18 Vertex
11.18.1 Vertex Company Detail
11.18.2 Vertex Business Overview
11.18.3 Vertex Biotechnology Introduction
11.18.4 Vertex Revenue in Biotechnology Business (2019-2024)
11.18.5 Vertex Recent Development
11.19 Jazz Pharmaceuticals
11.19.1 Jazz Pharmaceuticals Company Detail
11.19.2 Jazz Pharmaceuticals Business Overview
11.19.3 Jazz Pharmaceuticals Biotechnology Introduction
11.19.4 Jazz Pharmaceuticals Revenue in Biotechnology Business (2019-2024)
11.19.5 Jazz Pharmaceuticals Recent Development
11.20 Incyte
11.20.1 Incyte Company Detail
11.20.2 Incyte Business Overview
11.20.3 Incyte Biotechnology Introduction
11.20.4 Incyte Revenue in Biotechnology Business (2019-2024)
11.20.5 Incyte Recent Development
11.21 BioMarin
11.21.1 BioMarin Company Detail
11.21.2 BioMarin Business Overview
11.21.3 BioMarin Biotechnology Introduction
11.21.4 BioMarin Revenue in Biotechnology Business (2019-2024)
11.21.5 BioMarin Recent Development
11.22 Genmab
11.22.1 Genmab Company Detail
11.22.2 Genmab Business Overview
11.22.3 Genmab Biotechnology Introduction
11.22.4 Genmab Revenue in Biotechnology Business (2019-2024)
11.22.5 Genmab Recent Development
11.23 Novavax
11.23.1 Novavax Company Detail
11.23.2 Novavax Business Overview
11.23.3 Novavax Biotechnology Introduction
11.23.4 Novavax Revenue in Biotechnology Business (2019-2024)
11.23.5 Novavax Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Johnson & Johnson
Roche
Pfizer
Merck
Sanofi
AstraZeneca
Gilead
CELGENE CORPORATION
Biogen
Amgen
Abbott
Novo Nordisk
Novartis
Lonza
BioNTech
Moderna
Regeneron
Vertex
Jazz Pharmaceuticals
Incyte
BioMarin
Genmab
Novavax

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.